a Department of Pharmacy, School of Medicine, College of Health and Medicine , University of Tasmania , Tasmania , Australia.
b Unit for Medication Outcomes Research and Education , University of Tasmania , Tasmania , Australia.
Curr Med Res Opin. 2019 Jun;35(6):1119-1126. doi: 10.1080/03007995.2018.1560193. Epub 2019 Jan 11.
Potentially inappropriate medication (PIM) use is associated with increased morbidity and mortality in chronic kidney disease (CKD). However, there is a paucity of data on how hospitalization affects PIM use in older adults with CKD. Therefore, we aimed to measure the impact of hospitalization on PIM use in older CKD patients, and identify factors predicting PIM use.
A retrospective cohort study was conducted in older adults (≥65 years) with CKD admitted to an Australian tertiary care hospital over a 6 month period. PIM use was measured, upon admission and at discharge, using the Medication Appropriateness Index (MAI) and Beers criteria (2015 version) for medications recommended to be avoided in older adults and under certain conditions.
The median age of the 204 patients was 83 years (interquartile range (IQR): 76-87 years) and most were men (61%). Overall, the level of PIM use (MAI) decreased from admission to discharge (median [IQR]: 6 [3-12] to 5 [2-9]; p < .01]). More than half of the participants (55%) had at least one PIM per Beers criterion on admission, which was reduced by discharge (48%; p < .01). People admitted with a higher number of medications (β 0.72, 95% CI 0.56-0.88) and lower eGFR values (β - 0.11, 95% CI -0.18 to -0.04) had higher MAI scores after adjusting for age, sex and Charlson's comorbidity index.
PIMs were commonly used in older CKD patients. Hospitalization was associated with a reduction in PIM use, but there was considerable scope for improvement in these susceptible individuals.
在慢性肾脏病(CKD)患者中,不适当用药(PIM)与发病率和死亡率增加相关。然而,关于CKD 老年患者住院如何影响 PIM 使用的数据很少。因此,我们旨在衡量住院对老年 CKD 患者 PIM 使用的影响,并确定预测 PIM 使用的因素。
对在澳大利亚三级护理医院住院的 6 个月内的 CKD 老年患者(≥65 岁)进行回顾性队列研究。使用药物适宜性指数(MAI)和 Beers 标准(2015 年版)来衡量入院时和出院时的 PIM 使用情况,这些标准适用于建议避免在老年人中使用的药物以及在某些情况下使用的药物。
204 名患者的中位年龄为 83 岁(四分位距(IQR):76-87 岁),大多数为男性(61%)。总体而言,PIM 使用水平(MAI)从入院到出院时降低(中位数[IQR]:6[3-12]降至 5[2-9];p<0.01])。入院时,超过一半的患者(55%)符合至少一项 Beers 标准的 PIM,出院时减少至 48%(p<0.01)。在调整年龄、性别和 Charlson 合并症指数后,入院时使用的药物数量较多(β 0.72,95%CI 0.56-0.88)和 eGFR 值较低(β-0.11,95%CI-0.18 至-0.04)的患者 MAI 评分较高。
在 CKD 老年患者中,PIM 经常被使用。住院与 PIM 使用减少相关,但这些易受影响的个体仍有很大的改进空间。